| |
 |
AMA PRA Category 1 Credit(s)™
Release Date 1/24/2014
Expiration Date 1/24/2015 |
|
|
| |
|
|
| |
 |
Kimberly A. Brown, MD (Chair)
Henry Ford Hospital
Detroit, MI
|
|
| |
 |
|
| |
|
|
| |
 |
Robert S. Brown, Jr., MD, MPH
New York Presbyterian
New York, NY |
|
| |
|
|
| |
|
|
| |
 |
Steven L. Flamm, MD
Northwestern University
Chicago, IL |
|
| |
|
|
| |
|
|
| |
 |
Kris V. Kowdley, MD
Virginia Mason Medical Center
Seattle, WA |
|
| |
|
|
| |
|
|
| |
|
|
| |
 |
|
| |
|
|
| |
|
|
| |
|
| |
|
|
|
|
|
| Steven L. Flamm, MD |
Steven L. Flamm, MD, is a Professor of Medicine and Surgery with the Division of Hepatology at Northwestern University Feinberg School of Medicine in Chicago, Illinois. He serves as the Chief of Transplantation Hepatology and Medical Director of Liver Transplantation.
Dr. Flamm received his MD degree from the University of Pennsylvania School of Medicine. He completed both a clinical fellowship in gastroenterology and a research fellowship in gastroenterology and hepatology at Beth Israel Hospital, Harvard Medical School. He then went on for further specialized training, completing a clinical fellowship in hepatology and liver transplantation at The Deaconess Hospital, Harvard Medical School.
Dr. Flamm is a member of the American Gastroenterological Association and the American Association for the Study of Liver Diseases (AASLD). He has served as the Region 7 Representative to the UNOS Liver and Intestine Committee and on the Publication and Practice Guidelines Committees of the AASLD.
Dr. Flamm has published widely in the field of hepatic diseases and has spoken both nationally and internationally on many other liver-related topics including viral hepatitis, autoimmune hepatitis, hepatic encephalopathy, and liver transplantation. He has an active clinical research program for patients with many different chronic liver diseases including chronic viral hepatitis (HBV and HCV) and hepatic encephalopathy.
Speaker Disclosure:
Steven L. Flamm, MD, has disclosed that he has received grants for clinical research and grants for educational activities from Salix Pharmaceuticals, Inc. He has served as a consultant for and has participated on the speaker’s bureau for Salix Pharmaceuticals, Inc. In addition, he has participated on the advisory board for Salix Pharmaceuticals, Inc.
|
 |
| |
|
